Drugs for asthma and other chronic obstructive diseases of the lungs should be preferably delivered by the inhalation route to match therapeutic effects with low systemic exposure. Inhaled drugs are delivered to the lungs via different devices, mainly metered dose inhalers and dry powder inhalers, each characterized by specific inhaler technique and instructions for use. The patient-device interaction is part of the prescribed therapy and can have a relevant impact on adherence and clinical outcomes. The most suitable device should be considered for each patient to assure the correct drug intake and adherence to the prescribed therapy. The development of new drugs/devices in the past decades improved the compliance with inhaler and possibly drug delivery to the bronchi. The present review focuses on the recently developed beclomethasone/formoterol extrafine fixed combination and technical aspects of drug delivery to the lungs in patient's perspective.

Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations / G., Nicolini; N., Scichilone; A., Bizzi; A., Papi; Fabbri, Leonardo. - In: THERAPEUTICS AND CLINICAL RISK MANAGEMENT. - ISSN 1176-6336. - STAMPA. - 4:5(2008), pp. 855-864.

Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations.

FABBRI, Leonardo
2008

Abstract

Drugs for asthma and other chronic obstructive diseases of the lungs should be preferably delivered by the inhalation route to match therapeutic effects with low systemic exposure. Inhaled drugs are delivered to the lungs via different devices, mainly metered dose inhalers and dry powder inhalers, each characterized by specific inhaler technique and instructions for use. The patient-device interaction is part of the prescribed therapy and can have a relevant impact on adherence and clinical outcomes. The most suitable device should be considered for each patient to assure the correct drug intake and adherence to the prescribed therapy. The development of new drugs/devices in the past decades improved the compliance with inhaler and possibly drug delivery to the bronchi. The present review focuses on the recently developed beclomethasone/formoterol extrafine fixed combination and technical aspects of drug delivery to the lungs in patient's perspective.
2008
4
5
855
864
Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations / G., Nicolini; N., Scichilone; A., Bizzi; A., Papi; Fabbri, Leonardo. - In: THERAPEUTICS AND CLINICAL RISK MANAGEMENT. - ISSN 1176-6336. - STAMPA. - 4:5(2008), pp. 855-864.
G., Nicolini; N., Scichilone; A., Bizzi; A., Papi; Fabbri, Leonardo
File in questo prodotto:
File Dimensione Formato  
TCRM-2008-4(5)-3126_Nicolini.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 375.46 kB
Formato Adobe PDF
375.46 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/962506
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 34
  • ???jsp.display-item.citation.isi??? ND
social impact